Cargando…
Circulating microRNA associated with future relapse status in major depressive disorder
Major depressive disorder (MDD) is an episodic condition with relapsing and remitting disease course. Elucidating biomarkers that can predict future relapse in individuals responding to an antidepressant treatment holds the potential to identify those patients who are prone to illness recurrence. Th...
Autores principales: | Li, Qingqin S., Galbraith, David, Morrison, Randall L., Trivedi, Madhukar H., Drevets, Wayne C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428445/ https://www.ncbi.nlm.nih.gov/pubmed/36061300 http://dx.doi.org/10.3389/fpsyt.2022.937360 |
Ejemplares similares
-
Personalized relapse prediction in patients with major depressive disorder using digital biomarkers
por: Vairavan, Srinivasan, et al.
Publicado: (2023) -
Meta-analysis of epigenome-wide association studies of major depressive disorder
por: Li, Qingqin S., et al.
Publicado: (2022) -
MicroRNAs as novel peripheral markers for suicidality in patients with major depressive disorder
por: Stapel, Britta, et al.
Publicado: (2022) -
Identifying circulating biomarkers for major depressive disorder
por: Zhang, En, et al.
Publicado: (2023) -
Economic burden of relapse/recurrence in patients with major depressive disorder
por: Gauthier, Genevieve, et al.
Publicado: (2019)